🇺🇸 FDA
Patent

US 6673335

Compositions and methods for the pulmonary delivery of aerosolized medicaments

expired A61KA61K38/21A61K38/215

Quick answer

US patent 6673335 (Compositions and methods for the pulmonary delivery of aerosolized medicaments) held by Nektar Therapeutics expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K38/21, A61K38/215, A61K38/28, A61K47/544